TAKP34 bonds
Below is the list of TAKEDAPH DRN corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
7.11% | 715 K | 64.44% | 3.18% | 2050-07-09 | 2 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
7.00% | 500 K | 63.15% | 3.38% | 2060-07-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.53% | 8.48 M | 73.27% | 3.03% | 2040-07-09 | 1.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 6.36% | 163 K | 90.22% | 5.25% | 2045-06-23 | 500.41 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
6.13% | 4.17 M | 96.24% | 5.80% | 2064-07-05 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.02% | 100 K | 96.05% | 5.65% | 2054-07-05 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.93% | 280 K | 97.52% | 5.65% | 2044-07-05 | 800 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.18% | 4.52 M | 100.78% | 5.30% | 2034-07-05 | 1.1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.04% | 13.52 M | 88.16% | 2.05% | 2030-03-31 | 2.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4.84% | 1.14 M | 99.87% | 4.00% | 2025-06-23 | 800.17 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4.66% | 0 | 98.07% | 3.20% | 2026-09-23 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Shire Acquisitions Investments Ireland DAC |
4.55% | 1 M | 101.40% | 5.00% | 2028-11-26 | 1.73 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
4.42% | 0 | 77.99% | 2.00% | 2040-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.36% | 0 | 88.49% | 1.38% | 2032-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.00% | 0 | 100.02% | 3.00% | 2030-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.75% | 0 | 93.41% | 1.00% | 2029-07-09 | 850 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.71% | 0 | 116.57% | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
2.48% | 0 | 96.39% | 0.75% | 2027-07-09 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.37% | 0 | 99.82% | 2.25% | 2026-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4.00% | 2025-06-23 | 303 K USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
— | — | — | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. |